Stay updated with breaking news from Ronald Silver. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com lowered shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) from a strong-buy rating to a buy rating in a research note issued to investors on Thursday morning. Separately, Piper Sandler increased their target price on Ironwood Pharmaceuticals from $16.00 to $19.00 in a research note on Tuesday, May 23rd. Ironwood Pharmaceuticals Stock Performance IRWD […]
Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Thursday. Separately, Piper Sandler lifted their price objective on Ironwood Pharmaceuticals from $16.00 to $19.00 in a research report on Tuesday. Ironwood Pharmaceuticals Stock Performance Shares of NASDAQ:IRWD opened at $10.81 […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 17,130,000 shares, a decrease of 14.9% from the April 15th total of 20,130,000 shares. Approximately 11.3% of the company’s stock are sold short. Based on an average […]
Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) issued its earnings results on Thursday. The biotechnology company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.01, Briefing.com reports. The business had revenue of $104.06 million for the quarter, compared to analyst estimates of $100.60 million. Ironwood Pharmaceuticals had a net […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) was the recipient of unusually large options trading activity on Thursday. Traders bought 4,553 call options on the stock. This is an increase of approximately 13,697% compared to the average volume of 33 call options. Insiders Place Their Bets In other Ironwood Pharmaceuticals news, COO Jason Rickard sold […]